Preventive Treatments for Breast Cancer | NYU Langone Health
Doctors at NYU Langone’s Perlmutter Cancer Center may recommend treatments to reduce the risk of developing breast cancer in women at high risk.
Primary Care & Specialty Services in Florida | NYU Langone Health
NYU Langone’s team of experts offers several convenient care locations across Palm Beach County, Florida.
Primary Care & Specialty Services in Florida Doctors | NYU Langone Health
Find a doctor at the Primary Care & Specialty Services in Florida at NYU Langone.
Primary Care Services | NYU Langone Health
NYU Langone physicians offer primary care and internal medicine services close to where you live and work.
Primary Care Services Doctors | NYU Langone Health
Find a doctor at the Primary Care Services at NYU Langone.
Primary Central Nervous System Lymphoma | NYU Langone Health
Perlmutter Cancer Center specialists collaborate to manage primary central nervous system lymphoma, an immune system cancer.
Primary Ciliary Dyskinesia Foundation (PCDF) Registry: A longitudinal study of patients with primary ciliary dyskinesia
PCD Foundation (PCDF) Registry:A longitudinal study of patients with primary ciliary dyskinesiaEstablishment of a registry will allow for an improved understanding of demographics, diagnostic testing, and clinical treatment needs of individuals with PCD currently followed at PCD Foundation Clinical and Research Center Network (CRCN) sites in North America.The objective of this proposal is to improve clinical care, quality of life and patient-important outcomes for individuals with primary ciliary dyskinesia (PCD) through establishment of a prospective multi-center registry. Aim 1: To establish a secure electronic repository of clinical information of patients with a confirmed or probable diagnosis of PCD.Aim 2: To systematically collect and evaluate longitudinal demographic information, diagnostic and monitoring test results, and clinical treatments/interventions data with the goal of developing new research questions that will guide improvements in PCD diagnostics, clinical care, quality of life and patient-important outcomes.
Proactive infliximab optimization using a pharmacokinetic dashboard versus standard of care in patients with Crohn s disease: The OPTIMIZE Trial
This is a randomized, controlled, multicenter, open-label study. All eligible subjects will be randomly assigned in a 1:1 ratio to receive either IFX monotherapy with proactive therapeutic drug monitoring (TDM) using the iDose dashboard or SOC IFX therapy, with or without concomitant immunomodulator (IMM) therapy, and empiric dose optimization or reactive TDM, at the discretion of the investigator. Assuming sustained CS-free clinical remission in SOC IFX at follow-up to be 25%, the study with a total of 196 subjects would be able to detect the difference of 20% in sustained CS-free clinical remission between iDose and SOC IFX with 80% power at the 2-sided 5% significance level, adjusting for approximately 10% loss to follow-up. All subjects in both treatment groups will receive intravenous (IV) infusions of 5 mg/kg of IFX at Weeks 0 and 2. After Week 2, subjects in the proactive iDose-driven dosing arm will receive subsequent IFX with infusion doses and/or intervals guided by the iDose dashboard. The third infusion in the iDose group will be administered as 5 mg/kg using an interval forecasted by the iDose dashboard and dosing above 5 mg/kg will be an option based on iDose starting at the fourth infusion. Subjects in the SOC dosing arm will receive a third IV infusion of 5 mg/kg IFX at Week 6 and then maintenance therapy with infusions every 8 weeks thereafter. In this group, treating physicians may use empiric dose optimization or reactive TDM in accordance with their usual care practices. Subjects in the SOC group may also be prescribed a concomitant IMM (thiopurine or methotrexate [MTX]) if the treating physician would normally do so as part of usual care. Subjects in the iDose group will be prohibited from using thiopurines or MTX throughout the study.
Procedures for Ventricular Arrhythmias | NYU Langone Health
NYU Langone doctors use catheter ablation and electrical shocks to manage the symptoms of ventricular arrhythmias.
Procedures to Treat Retinal Tears & Retinal Detachments | NYU Langone Health
NYU Langone ophthalmologists use noninvasive procedures for retinal tears and detachments, and surgery may be needed for some detachments.